No vaccines exist that protect people against infections by coronaviruses, including SARS-CoV-2, which causes COVID-19, or the ones that cause SARS and MERS. As COVID-19 continues to wreak havoc, many labs around the world have developed a laser-like focus on understanding the virus and finding the best strategy for stopping it.
Researchers have identified the most common clinical characteristics of 109 patients with COVID-19 related pneumonia who died in Wuhan, China in the early stages of the coronavirus pandemic, according to a new study published online in the Annals of the American Thoracic Society.
A team of researchers identified a way to measure frailty using patients’ medical claims that more accurately predict costs-of-care, especially for clinicians with disproportionate shares of frail patients.
With support from Amazon Web Services, UC San Diego Health physicians are using AI in a clinical research study aimed at speeding the detection of pneumonia, a condition associated with severe COVID-19.
The COVID-19 pandemic is creating unprecedented challenges for children and parents. However, Bridget Boyd, MD, a Loyola Medicine pediatrician, says there are ways that parents can communicate, and actions that they can take, to protect children and help them to better understand, adapt to and recover from this experience.
In the new Loyola Medicine video, “COVID-19: What Parents Need to Know about Protecting Their Kids,” Dr. Boyd offers tips for parents and caregivers.
With the number of COVID-19 cases expected to surge in the U.S. and N95 mask supplies dwindling, medical communities are desperately looking for alternative solutions for disinfecting masks that healthcare workers are being forced to reuse. Nationally known expert in disinfectant methods, Jim Malley, professor of civil and environmental engineering at the University of New Hampshire, says methods like UV light, heat & humidity and vaporized hydrogen peroxide are the best known viable practices and while they are not long-term solutions, if used correctly, they can be effective in emergency situations.
As scientists race to develop and test new treatments for COVID-19, Dana-Farber’s Wayne Marasco, MD, PhD, and his lab team are bringing one of the world’s most formidable resources to the effort: a “library” of 27 billion human antibodies against viruses, bacteria, and other bodily invaders.The collection, created by Marasco and his associates in 1997 using blood samples from more than 57 Dana-Farber staff, has already had an illustrious history in the quest to tame viral disease outbreaks.
A team of Stony Brook University (SBU) researchers is working on computer models that could help speed the discovery of drugs to combat the novel coronavirus responsible for COVID-19. They are doing this work in collaboration with scientists at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory and Argonne National Laboratory, and will be leveraging those laboratories’ computational resources and expertise.
In its continuing efforts to encourage colleges and universities across the country to share resources and facilities with local hospitals and communities to relieve unprecedented strain on the healthcare system caused by COVID-19, Tufts University today announced it is making available tools and guidance to help facilitate relationships between schools and their local healthcare providers and government authorities.
The fastest recipe for worldwide access to a coronavirus vaccine may be to build upon on an existing vaccine with an already established manufacturing and supply chain.
Today, the American Thoracic Society announced that Boehringer Ingelheim Pharmaceuticals, Inc., donated $500,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. Boehringer Ingelheim is the first to make a donation to the Fund.
The COVID-19 pandemic is an example of complexity in action. Researchers who study complex systems are available to answer questions on topics such as why systems collapse, the nature of an evolving virus and its ecology, how networks spread disease and economic instability, the mathematics of modeling outbreaks, the way decision-making modifies disease spread, and other ideas that touch on the disease.
The following are various story ideas regarding the COVID-19 illness. To interview experts in these tips or others at Johns Hopkins, contact [email protected].
By comparing Twitter data from before and after the COVID-19 outbreak, Johns Hopkins University researchers found a profound impact on the movement of Americans – indicating social distancing recommendations are having an effect.
With the rapid spread of the Coronavirus (COVID-19), LifeBridge Health, one of the largest healthcare systems in Maryland, ramped up its tele-triage program to help reduce an overflow of concerned patients in the system’s emergency departments and provider offices in the community.
Hospitals can prepare for a surge of patients critically ill with COVID-19, but it will require hospital leaders, practitioners and regional officials to adopt drastic measures that challenge the standard way of providing care, according to a new RAND Corporation report.
A team of physician-scientists at Beth Israel Deaconess Medical Center are now enrolling patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with ARDS. The newly launched trial follows a special report the team published in the Journal of Trauma and Acute Care Surgery that suggested the use of a drug called tPA could reduce deaths among patients with ARDS as a complication of COVID-19.
Consuming a diet high in fiber was linked with a reduced incidence of breast cancer in an analysis of all relevant prospective studies. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society
In the battle to keep workers safe during the COVID-19 pandemic, nearly 40 craft distilleries in New York state have turned to making hand sanitizer with guidance from Cornell University.
The world has been hit hard by coronavirus, and health services and authorities everywhere are struggling to reduce the spread, combat the disease and protect the population.
A point-of-care testing device that may help diagnose the novel coronavirus disease (COVID-19) is under development by Weihua Guan, assistant professor of electrical engineering in Penn State’s College of Engineering.
Of the seven coronaviruses known to infect people, four cause common respiratory infections that are sharply seasonal and appear to transmit similarly to influenza, according to a new study by University of Michigan School of Public Health researchers.
The N95 respirator masks should be preserved for health-care workers involved in inserting breathing tubes for patients with COVID-19. More common medical masks are fine for all other COVID-19 treatment, says preliminary research from McMaster University.
UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.
The Rutgers COVID Response Pandemic Preparedness Center, which is coordinating the university’s myriad research, public health, and outreach efforts to combat COVID-19, has named Henry F. Raymond, associate professor in the department of biostatistics and epidemiology at the Rutgers School of Public Health, as it’s associate director for public health.
Benjamin Brewer, PsyD, is a University of Colorado Cancer Center investigator and health psychologist at the UCHealth University of Colorado Hospital Bone Marrow Transplant Program. Here CU Cancer Center talks with Dr. Brewer about his patients’ new worries and about how our health system is adapting to meet the mental health needs of cancer patients during COVID-19.
Scientists and staff at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory are marshalling their expertise, unique facilities, and other key resources in the battle against COVID-19.
Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19).
Robert Laumbach, a Rutgers occupational and an environmental medicine expert, and associate professor at the Rutgers School of Public Health’s Environmental and Occupational Health Sciences Institute (EOHSI), discusses the dangers of DIY cleaning products and how the public can safely make their own.
Michael McLaughlin, an assistant professor and assistant program director of the Rutgers Nurse Anesthesia program, who has been on the frontlines of the COVID-19 crisis and intubated many COVID-19 patients, discusses how this conversion works and how it helps to alleviate the ventilator shortage
– The Monday Campaigns, a nonprofit public health initiative, has announced Sherri Snelling, caregiving expert and corporate gerontologist, is taking a leading role with Caregiver Monday, a program dedicated to supporting the self-care of 65 million family caregivers by offering weekly health and wellness practices, research and collaborative activities through partner organizations.
A simple, low-cost ventilator based on the resuscitation bags carried in ambulances – and widely available in hospitals – has been designed by an international team of university researchers. The device, which is powered by a 12-volt motor, could help meet peak medical demands in the industrialized world and serve resource-constrained countries that don’t have supplies of conventional ventilators.
The National Institutes of Health has awarded Tulane National Primate Research Center a contract of up to $10.3 million to evaluate vaccines and treatments to combat coronavirus disease 2019.
ROLLA, Mo. – The day before the federal government issued new recommendations that Americans wear cloth face coverings to help slow the spread of the coronavirus, a researcher at Missouri University of Science and Technology decided to test a few common household materials – pillowcases, scarves, furnace filters – “out of curiosity.
There are some critical things to know about how to use a nonmedical mask correctly, because when used incorrectly, which is pretty easy to do, you could actually put yourself and others more at risk. Physicians at UTHealth break it all down.
An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment. The new guidance – “COVID-19: Interim Guidance on Management Pending Empirical Evidence”– is published as an open access document on the American Thoracic Society’s website.
El sinhogarismo se ha convertido en una crisis social y un problema de la salud pública en todo el mundo y afecta a gente de toda edad. La mayoría de las personas sin hogar están en desventaja porque tienen menos recursos y, posiblemente, no cuentan con un buen seguro de salud.
Xue Ming, a professor of neurology at Rutgers New Jersey Medical School, and a specialist in sleep disorders, talks about how COVID-19 is bringing new challenges to sleep cycles, how sleep helps the immune system fight inflammation, infection and disease while producing proteins that are needed to recover from illness, and what can be done to get on the right track to a healthy sleep routine.
A new remote monitoring platform developed by the Mount Sinai Health System is helping health care providers to care for COVID-19 patients who are recovering at home.
NYU's Jennifer Pomeranz says that existing warnings on other products should offer a roadmap for labeling sugary drinks—without violating the First Amendment.
The FDA’s announcement Friday to approve convalescent serum therapy as a large-scale clinical trial opened the door for more patients to receive the potentially life-saving gift of a donor’s plasma.
Without immediate action, limited supplies of personal protective equipment (PPE), ventilators and other lifesaving equipment will cause greater loss of life and increase the toll from COVID-19, warns the American Association of Critical-Care Nurses